Patents by Inventor Markku Michael Jeltsch

Markku Michael Jeltsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Growth Factor Binding Constructs Materials and Methods
    Publication number: 20110243912
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
    Type: Application
    Filed: December 17, 2010
    Publication date: October 6, 2011
    Applicant: VEGENICS LIMITED
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
    Publication number: 20110207664
    Abstract: The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
    Type: Application
    Filed: January 28, 2011
    Publication date: August 25, 2011
    Applicant: VEGENICS PTY LIMITED
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Growth factor binding constructs materials and methods
    Patent number: 7855178
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: December 21, 2010
    Assignee: Vegenics Limited
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
    Publication number: 20090318352
    Abstract: The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
    Type: Application
    Filed: April 10, 2009
    Publication date: December 24, 2009
    Applicant: VEGENICS LIMITED
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Growth Factor Binding Constructs Materials and Methods
    Publication number: 20090155268
    Abstract: The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
    Type: Application
    Filed: July 28, 2008
    Publication date: June 18, 2009
    Applicant: VEGENICS LIMITED
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
    Patent number: 6965010
    Abstract: The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: November 15, 2005
    Assignees: Licentia, Ltd., Ludwig Institute for Cancer Research
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
    Publication number: 20020151680
    Abstract: The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
    Type: Application
    Filed: February 26, 2001
    Publication date: October 17, 2002
    Inventors: Kari Alitalo, Markku Michael Jeltsch
  • Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B
    Publication number: 20020068694
    Abstract: N-glycosylated VEGF-B proteins, nucleic molecule encoding these proteins, pharmaceutical compositions containing them and a method for increasing the amount of a soluble VEGF-B protein. The VEGF-B proteins are useful in stimulating and maintaining angiogenesis.
    Type: Application
    Filed: July 26, 2001
    Publication date: June 6, 2002
    Inventors: Markku Michael Jeltsch, Kari Alitalo, Birgitta Olofsson, Ulf Eriksson